276 Views
Sunday Poster Session
Category: Colon
Janice Cho, MD
Mayo Clinic
Rochester, MN, United States
Bile acid | No GI symptoms (N = 25) | GI symptoms (N = 10) | P-value |
Total primary BA at diagnosis | 1.1 (0.2, 8) | 1.4 (0.2, 147.7) | 0.92 |
CDCA at diagnosis | 0.4 (0.1, 3.6) | 0.2 (0.1, 3.4) | 0.95 |
CA at diagnosis | 0.5 (0.1, 3.8) | 0.9 (0.1, 7.8) | 0.77 |
Total secondary BA at diagnosis | 3.2 (0.6, 14.3) | 10.8 (1, 30.3) | 0.25 |
LCA at diagnosis | 0.4 (0.1, 5.0) | 4.2 (0.4, 5.6) | 0.20 |
DCA at diagnosis | 0.5 (0.3, 5.5) | 6.2 (0.4, 15.1) | 0.18 |
UDCA at diagnosis | 0.3 (0, 0.9) | 0.2 (0.1, 0.3) | 0.77 |
Primary to secondary BA ratio at diagnosis | 0.4 (0.1, 1.7) | 0.8 (0, 1.6) | 0.75 |
| | | |
No GI symptoms (N = 20) | GI symptoms (N = 6) | | |
Total primary BA at end-of-treatment | 16.4 (9.3, 33.1) | 11.8 (5.2, 15.6) | 0.38 |
CDCA at end-of-treatment | 4.4 (1.8, 7.6) | 1.5 (1.2, 1.9) | 0.06 |
CA at end-of-treatment | 11 (6.1, 23.1) | 11.1 (3.9, 13.7) | 0.69 |
Total secondary BA at end-of-treatment | 1 (0.3, 5.3) | 2.1 (0.5, 2.7) | 0.95 |
LCA at end-of-treatment | 0.2 (0, 0.4) | 0 (0, 0.4) | 0.36 |
DCA at end-of-treatment | 0.2 (0.2, 0.4) | 0.3 (0.1, 0.7) | 0.83 |
UDCA at end-of-treatment | 0.3 (0, 4.3) | 0.7 (0.2, 0.2) | 0.88 |
Primary to secondary BA ratio at end-of-treatment | 21.5 (2.6, 96.9) | 12 (2.2, 32.6) | 0.69 |
| | | |
End-of-treatment primary to secondary BA ratio >1 | End-of-treatment primary to secondary BA ratio < 1 | | |
Patients with GI symptoms suggestive of IBS after CDI (total N = 6) | 5 (83.3%) | 1 (16.7%) | |
Patients who did not develop GI symptoms suggestive of IBS after CDI (total N = 20) | 17 (85%) | 3 (15%) | |